Active09220619Private limited companyFolkestone

CLINICAL OUTCOMES SOLUTIONS LTD

Significant control: Stacie Ann Hudgens (75–100%)

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Clinical Outcomes Solutions Ltd: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Clinical Outcomes Solutions Ltd sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

CLINICAL OUTCOMES SOLUTIONS LTD is an active private limited company (company number 09220619) incorporated on 16 September 2014, registered in Folkestone. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (total exemption full) but not yet parsed into this record.

There are 59 companies in research and experimental development on biotechnology in Kent with filed accounts; the median reports net assets of £2,535 and is 7 years old.

Ownership and control

1 active · 3 other

SA
Ms Stacie Ann Hudgens
Individual · since 10 February 2023
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
75–100%
TL
Ms Tara Louise Symonds
Individual · since 6 April 2016 · ceased 7 May 2021
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%
SA
Ms Stacie Ann Hudgens
Individual · since 6 April 2016 · ceased 7 May 2021
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%
persons with significant control statement · since 21 May 2021 · ceased 10 February 2023

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 16 September 201412 yrs ago
First accounts due: 16 June 20163785 days overdue
Confirmation statement due: 30 September 2027in 338 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
Accounts type: Total Exemption Full

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

Filing and accounts signals

Facts from the register · no rating

Incorporated five or more years agoIncorporated 16 September 2014
Accounts past their due dateDue 16 June 2016

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

30 Sept 2027Confirmation statement duein 338 days
16 Jun 2016First accounts due3785 days overdue
16 Sept 2014Incorporated

Similar companies in Kent

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 16 September 2014 · in Sept 2014.

Reminders for CLINICAL OUTCOMES SOLUTIONS LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.